NAV | $25.55 | Daily Change | $0.33 | 1.32% |
Market Price | $25.70 | Daily Change | $0.41 | 1.60% |
Humans are living longer than ever, with forecasts suggesting the global population of adults age 60+ could double to more than 2bn by 2050.1
With a ballooning senior population, particularly in western countries, we expect to see waves of innovation catering to their distinct consumer preferences.
The Aging Population theme is a global trend, affecting a wide range of industries. AGNG invests accordingly, offering exposure to companies regardless of sector or geographic classification.
1WHO, Oct 2021
Inception Date | 05/09/16 |
Total Expense Ratio | 0.50% |
Net Assets | $50.33 million |
NAV | $25.55 |
Fact Sheet |
The Global X Aging Population ETF (AGNG) seeks to invest in companies positioned to serve the world’s growing senior population through exposure to health care, pharmaceuticals, senior living facilities and other sectors that contribute to increasing lifespans and extending quality of life in advanced age.
The Global X Aging Population ETF (AGNG) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Aging Population Thematic Index.
Ticker | AGNG |
Bloomberg Index Ticker | ILNGRNT |
CUSIP | 37954Y772 |
ISIN | US37954Y7720 |
Primary Exchange | Nasdaq |
Shares Outstanding | 1,970,000 |
Number of Holdings | 99 |
30-Day Median Bid-Ask Spread | 0.27% |
30-Day SEC Yield | 0.84% |
Distribution Frequency | Semi-Annually |
NAV | $25.55 | Daily Change | $0.33 | 1.32% |
Market Price | $25.70 | Daily Change | $0.41 | 1.60% |
As of recent (03/31/22)
As of recent (03/31/22)
|
Fund NAV | Market Price | Index |
---|---|---|---|
1 Year | 4.32% | 4.02% | 4.46% |
3 Years | 10.88% | 10.69% | 11.09% |
5 Years | 12.10% | 11.95% | 12.34% |
Since Inception | 12.17% | 12.57% | 12.45% |
1 Year | -9.88% | -9.60% | -9.99% |
3 Years | 9.80% | 9.62% | 10.01% |
5 Years | 8.79% | 8.67% | 9.01% |
Since Inception | 10.12% | 10.56% | 10.39% |
Year-to-Date | -0.59% | -0.52% | -0.57% |
1 Month | 5.83% | 5.91% | 5.82% |
3 Months | -0.59% | -0.52% | -0.57% |
Since Inception | 96.77% | 100.92% | 99.78% |
Year-to-Date | -9.40% | -9.06% | -9.36% |
1 Month | -1.95% | -1.73% | -1.94% |
3 Months | -3.55% | -3.18% | -3.53% |
Since Inception | 79.33% | 83.67% | 82.12% |
Cumulative return is the aggregate amount that an investment has gained or lost over time. Annualized return is the average return gained or lost by an investment each year over a given time period.
The performance data quoted represents past performance. Past performance does not guarantee future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than their original cost and current performance may be lower or higher than the performance quoted. High short-term performance of the Fund, when observed, is unusual and investors should not expect such performance to be repeated.
Net Assets (%) | Ticker | Name | SEDOL | Market Price ($) | Shares Held | Market Value ($) |
---|---|---|---|---|---|---|
3.62 | LLY | ELI LILLY & CO | 2516152 | 324.71 | 5,607 | 1,820,648.97 |
3.48 | BMY | BRISTOL-MYERS SQUIBB CO | 2126335 | 76.84 | 22,761 | 1,748,955.24 |
3.36 | JNJ | JOHNSON & JOHNSON | 2475833 | 179.52 | 9,409 | 1,689,103.68 |
3.35 | AMGN | AMGEN INC | 2023607 | 245.55 | 6,860 | 1,684,473.00 |
3.25 | AZN | ASTRAZENECA PLC-SPONS ADR | 2989044 | 65.95 | 24,822 | 1,637,010.90 |
3.23 | NOVOB DC | NOVO NORDISK A/S-B | BHC8X90 | 109.59 | 14,816 | 1,623,676.90 |
3.10 | ABBV | ABBVIE INC | B92SR70 | 153.80 | 10,149 | 1,560,916.20 |
3.02 | ALC SW | ALCON INC | BJT1GR5 | 69.99 | 21,686 | 1,517,851.15 |
2.92 | WELL | WELLTOWER INC | BYVYHH4 | 83.21 | 17,659 | 1,469,405.39 |
2.90 | BSX | BOSTON SCIENTIFIC CORP | 2113434 | 38.01 | 38,446 | 1,461,332.46 |
2.87 | RO SW | ROCHE HOLDING AG-BR | 7108918 | 386.19 | 3,738 | 1,443,587.85 |
2.86 | REGN | REGENERON PHARMACEUTICALS | 2730190 | 595.40 | 2,420 | 1,440,868.00 |
2.81 | MDT | MEDTRONIC PLC | BTN1Y11 | 91.38 | 15,463 | 1,413,008.94 |
2.77 | EW | EDWARDS LIFESCIENCES CORP | 2567116 | 97.39 | 14,305 | 1,393,163.95 |
2.68 | 4519 JP | CHUGAI PHARMA CO | 6196408 | 25.73 | 52,336 | 1,346,408.14 |
2.61 | SYK | STRYKER CORP | 2853688 | 203.86 | 6,442 | 1,313,266.12 |
2.41 | SGEN | SEAGEN INC | BLPK4D2 | 180.11 | 6,730 | 1,212,140.30 |
2.26 | BIIB | BIOGEN INC | 2455965 | 210.63 | 5,410 | 1,139,508.30 |
2.09 | DXCM | DEXCOM INC | B0796X4 | 77.63 | 13,516 | 1,049,247.08 |
2.05 | 4503 JP | ASTELLAS PHARMA INC | 6985383 | 15.24 | 67,578 | 1,029,562.32 |
1.65 | 4543 JP | TERUMO CORP | 6885074 | 29.70 | 27,952 | 830,191.88 |
1.64 | ZBH | ZIMMER BIOMET HO | 2783815 | 107.27 | 7,704 | 826,408.08 |
1.59 | GMAB DC | GENMAB A/S | 4595739 | 329.77 | 2,419 | 797,723.15 |
1.54 | VTR | VENTAS INC | 2927925 | 52.74 | 14,705 | 775,541.70 |
1.49 | SOON SW | SONOVA HOLDING AG-REG | 7156036 | 321.41 | 2,325 | 747,282.64 |
1.39 | STMN SW | STRAUMANN HOLDING AG-REG | BQ7ZV06 | 119.70 | 5,860 | 701,435.76 |
1.39 | 068270 KS | CELLTRION INC | B0C5YV1 | 137.97 | 5,076 | 700,353.80 |
1.26 | INCY | INCYTE CORP | 2471950 | 77.67 | 8,143 | 632,466.81 |
1.25 | BGNE | BEIGENE LTD-ADR | BYYWPW6 | 166.95 | 3,775 | 630,236.25 |
1.22 | UCB BB | UCB SA | 5596991 | 85.83 | 7,158 | 614,401.45 |
1.15 | PODD | INSULET CORP | B1XGNW4 | 226.46 | 2,547 | 576,793.62 |
1.06 | FME GR | FRESENIUS MEDICA | 5129074 | 49.44 | 10,782 | 533,094.56 |
0.88 | SN/ LN | SMITH & NEPHEW PLC | 0922320 | 13.81 | 32,148 | 444,039.55 |
0.87 | TFX | TELEFLEX INC | 2881407 | 255.09 | 1,725 | 440,030.25 |
0.87 | 3692 HK | HANSOH PHARMACEU | BJYKB72 | 2.02 | 217,643 | 439,343.83 |
0.85 | ABMD | ABIOMED INC | 2003698 | 254.56 | 1,674 | 426,133.44 |
0.78 | UTHR | UNITED THERAPEUTICS CORP | 2430412 | 238.00 | 1,658 | 394,604.00 |
0.69 | NBIX | NEUROCRINE BIOSC | 2623911 | 99.25 | 3,500 | 347,375.00 |
0.67 | DEMANT DC | DEMANT A/S | BZ01RF1 | 38.01 | 8,826 | 335,438.42 |
0.66 | AGL | AGILON HEALTH INC | BLR4TK4 | 22.60 | 14,742 | 333,169.20 |
0.65 | COH AU | COCHLEAR LTD | 6211798 | 135.18 | 2,418 | 326,863.41 |
0.59 | DVA | DAVITA INC | 2898087 | 83.11 | 3,540 | 294,209.40 |
0.56 | NVCR | NOVOCURE LTD | BYSS4X4 | 73.30 | 3,837 | 281,252.10 |
0.52 | EXAS | EXACT SCIENCES CORP | 2719951 | 41.13 | 6,402 | 263,314.26 |
0.52 | AMP IM | AMPLIFON SPA | B14NJ71 | 31.58 | 8,321 | 262,776.61 |
0.50 | EXEL | EXELIXIS INC | 2576941 | 21.57 | 11,731 | 253,037.67 |
0.50 | OHI | OMEGA HEALTHCARE | 2043274 | 28.79 | 8,777 | 252,689.83 |
0.48 | 1858 HK | BEIJING CHUNLI-H | BVVPXP6 | 1.72 | 140,916 | 241,718.57 |
0.45 | HALO | HALOZYME THERAPEUTICS INC | 2975098 | 44.48 | 5,055 | 224,846.40 |
0.43 | 853 HK | MICROPORT SCIENTIFIC CORP | B676TW7 | 2.90 | 73,902 | 214,260.56 |
0.40 | RDUS | RADIUS HEALTH INC | BM68KK1 | 10.48 | 19,104 | 200,209.92 |
0.40 | 1789 HK | AK MEDICAL HOLDINGS LTD | BFD6SZ0 | 0.75 | 265,789 | 199,167.73 |
0.39 | 2500 HK | VENUS MEDTECH -H | BL6V047 | 2.23 | 87,040 | 194,116.11 |
0.38 | GN DC | GN STORE NORD A/S | 4501093 | 36.18 | 5,254 | 190,068.51 |
0.37 | NHI | NATL HEALTH INVESTORS INC | 2626125 | 61.59 | 3,042 | 187,356.78 |
0.36 | 1302 HK | LIFETECH SCIENTIFIC CORP | BV9FKS0 | 0.37 | 497,192 | 183,116.14 |
0.36 | LHCG | LHC GROUP INC | B06DT50 | 155.05 | 1,162 | 180,168.10 |
0.36 | LTC | LTC PROPERTIES INC | 2498788 | 38.82 | 4,605 | 178,766.10 |
0.35 | SBRA | SABRA HEALTH CAR | B5NLBP6 | 14.29 | 12,317 | 176,009.93 |
0.35 | MNKD | MANNKIND CORP | BF081J4 | 3.98 | 43,718 | 173,997.64 |
0.34 | NHC | NATIONAL HEALTHCARE CORP | 2139731 | 70.89 | 2,435 | 172,617.15 |
0.34 | TBPH | THERAVANCE BIOPHARMA INC | BMNDK09 | 9.73 | 17,636 | 171,598.28 |
0.34 | 4547 JP | KISSEI PHARM CO | 6494061 | 19.43 | 8,753 | 170,052.36 |
0.33 | AERI | AERIE PHARMACEUTICALS INC | BFRTDG1 | 8.36 | 19,885 | 166,238.60 |
0.32 | 8086 JP | NIPRO CORP | 6641599 | 7.91 | 20,508 | 162,254.76 |
0.32 | DNLI | DENALI THERAPEUTICS INC | BD2B4V0 | 31.24 | 5,127 | 160,167.48 |
0.32 | NUVA | NUVASIVE INC | B00GJC2 | 50.26 | 3,184 | 160,027.84 |
0.32 | ITGR | INTEGER HOLDINGS CORP | BD06LM7 | 72.00 | 2,212 | 159,264.00 |
0.31 | ANGO | ANGIODYNAMICS INC | B00CR04 | 19.54 | 7,960 | 155,538.40 |
0.31 | SILK | SILK ROAD MEDICAL INC | BGHVXJ7 | 38.94 | 3,989 | 155,331.66 |
0.31 | 2186 HK | LUYE PHARMA GROUP LTD | BNQ4GF3 | 0.33 | 469,424 | 154,343.96 |
0.31 | EKTAB SS | ELEKTA AB-B SHS | B0M42T2 | 6.98 | 22,023 | 153,670.86 |
0.31 | FGEN | FIBROGEN INC | BSDRYR8 | 11.40 | 13,463 | 153,478.20 |
0.30 | ENSG | ENSIGN GROUP INC/THE | B1YWPP8 | 75.69 | 2,019 | 152,818.11 |
0.29 | PHM SM | PHARMA MAR SA | BMW2GT8 | 71.18 | 2,082 | 148,201.22 |
0.29 | RYM NZ | RYMAN HEALTHCARE LTD | 6161525 | 5.40 | 27,301 | 147,462.75 |
0.29 | SGHT | SIGHT SCIENCES INC | BN2T5Q6 | 10.14 | 14,399 | 146,005.86 |
0.29 | MMSI | MERIT MEDICAL SYSTEMS INC | 2580555 | 54.96 | 2,622 | 144,105.12 |
0.28 | CSH-U CN | CHARTWELL RETIRE | B8S8C94 | 8.63 | 16,418 | 141,660.44 |
0.28 | CANO | CANO HEALTH INC | BN0WWW2 | 4.60 | 30,650 | 140,990.00 |
0.28 | SIA CN | SIENNA SENIOR LIVING INC | BWTYXH4 | 10.05 | 13,788 | 138,600.21 |
0.27 | LIVN | LIVANOVA PLC | BYMT0J1 | 63.30 | 2,150 | 136,095.00 |
0.27 | AMED | AMEDISYS INC | 2024332 | 110.82 | 1,220 | 135,200.40 |
0.27 | GKOS | GLAUKOS CORP | BYMWL19 | 47.66 | 2,835 | 135,116.10 |
0.27 | ALEC | ALECTOR INC | BJ4LDC4 | 11.02 | 12,173 | 134,146.46 |
0.27 | AGIO | AGIOS PHARMACEUTICALS INC | BCBVTX1 | 23.36 | 5,718 | 133,572.48 |
0.26 | AED BB | AEDIFICA | B1G5XP1 | 95.19 | 1,352 | 128,692.33 |
0.25 | INGN | INOGEN INC | BJSVLL5 | 24.50 | 5,209 | 127,620.50 |
0.24 | BPMC | BLUEPRINT MEDICINES CORP | BWY52P3 | 49.93 | 2,453 | 122,478.29 |
0.24 | PNTG | PENNANT GROUP INC/THE | BKTC976 | 12.88 | 9,392 | 120,968.96 |
0.23 | KORI FP | KORIAN | B1HKRM0 | 14.83 | 7,948 | 117,858.88 |
0.23 | BKD | BROOKDALE SR | B0PZN33 | 4.53 | 25,366 | 114,907.98 |
0.22 | DHC | DIVERSIFIED HEAL | BKRN595 | 1.89 | 59,304 | 112,084.56 |
0.21 | ORP FP | ORPEA | 7339451 | 23.58 | 4,403 | 103,815.85 |
0.18 | CMAX | CAREMAX INC | BMD9BG0 | 4.05 | 22,518 | 91,197.90 |
0.18 | ACAD | ACADIA PHARMACEU | 2713317 | 14.37 | 6,293 | 90,430.41 |
0.18 | ATEC | ALPHATEC HOLDINGS INC | BD60BG7 | 6.68 | 13,335 | 89,077.80 |
0.15 | HRTX | HERON THERAPEUTICS INC | BJ0XLZ3 | 2.72 | 27,244 | 74,103.68 |
0.13 | AMRN | AMARIN CORP PLC -ADR | 2301938 | 1.44 | 46,424 | 66,850.56 |
0.08 | CASH | 1.00 | 41,873 | 41,706.39 |
Sector | Weight (%) | |
---|---|---|
Health Care | 93.2 | |
Real Estate | 6.8 |
Source: AltaVista Research, LLC
Country | Weight (%) | |
---|---|---|
United States | 58.1 | |
Switzerland | 9.1 | |
Japan | 7.3 | |
Denmark | 5.8 | |
Britain | 5.1 | |
China | 3.5 | |
Ireland | 3.1 | |
Belgium | 1.5 | |
South Korea | 1.3 | |
Germany | 1.3 | |
Australia | 0.8 | |
Other/Cash | 3.1 |
Source: AltaVista Research, LLC
Return on Equity | 12.10% | |
Weighted Avg. Market Cap | 87,439 M | |
2021 | 2022 | |
Price-to-earnings | 25.09 | 26.32 |
Price-to-book value | 3.32 | 3.08 |
Source: AltaVista Research, LLC
Versus | Beta |
---|---|
S&P 500 | 0.77 |
MSCI EAFE | 0.75 |
MSCI Emg. Mkts | 0.61 |
Standard Deviation | 17.50% |
Source: AltaVista Research, LLC
Investing involves risk, including the possible loss of principal. The investable universe of companies in which AGNG may invest may be limited. The Fund invests in securities of companies engaged in Healthcare, Pharmaceutical, Biotechnology and Medical Device sectors. These sectors can be affected by government regulations, expiring patents, rapid product obsolescence, and intense industry competition. International investments may involve risk of capital loss from unfavorable fluctuation in currency values, from differences in generally accepted accounting principles or from social, economic or political instability in other nations. AGNG is non-diversified.
Shares of ETFs are bought and sold at market price (not NAV) and are not individually redeemed from the Fund. Brokerage commissions will reduce returns. Beginning October 15, 2020, market price returns are based on the official closing price of an ETF share or, if the official closing price isn’t available, the midpoint between the national best bid and national best offer (“NBBO”) as of the time the ETF calculates current NAV per share. Prior to October 15, 2020, market price returns were based on the midpoint between the Bid and Ask price. NAVs are calculated using prices as of 4:00 PM Eastern Time. The returns shown do not represent the returns you would receive if you traded shares at other times. Indices are unmanaged and do not include the effect of fees, expenses or sales charges. One cannot invest directly in an index.
Carefully consider the Fund’s investment objectives, risks, and charges and expenses before investing. This and other information can be found in the Fund’s summary or full prospectuses. Please read the prospectus carefully before investing.
Global X Management Company LLC serves as an advisor to Global X Funds. The Funds are distributed by SEI Investments Distribution Co. (SIDCO), which is not affiliated with Global X Management Company LLC or Mirae Asset Global Investments. Global X Funds are not sponsored, endorsed, issued, sold or promoted by Indxx, nor does Indxx make any representations regarding the advisability of investing in the Global X Funds. Neither SIDCO, Global X nor Mirae Asset Global Investments are affiliated with Indxx.
AGNG traded under the ticker LNGR from inception until April 1, 2021.